Cabotegravir is an anti-retroviral drug belonging to the Integrase Inhibitor class of drugs. It is being investigated to treat and prevent HIV infection both as an oral drug and as long acting injection.

This drug is missing the following documents, can you help us by contributing something?

Patent Information

Information of patent applications filed at local or international levels, that are contributed by the users of PODB as being relevant to this medicine

Please note that PODB does not provide and guarantee the comprehensive patent landscape in all countries.

*For more knowledge of patent search, please refer to the tutorial Step 2: Patent Search & Analysis
*For more information of the patent landscape on medicines, please also refer to WHO patent landscape reports, UNITAID patent landscape reports, Medicines Patent Pool Patent Status Database

Patent Applications

The table includes information of patent applications as filed in different countries, that are contributed by PODB users as being seen as relevant to this medicine.

CountryFiling datePriority dateApplicantNational numberInternational numberStatusPatent typeMore info
India13-01-2011VIIV Healthcare Company and Shionogogi & Co Ltd196/KOLNP/2011WO/2010/011814GrantedPro-DrugView/Comment
India07-03-2013VIIV Healthcare Company637/KOLNP/2013WO/2012/037320GrantedFormulationsView/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top